+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Microbiome Global Market Report 2024

  • PDF Icon

    Report

  • 250 Pages
  • February 2024
  • Region: Global
  • The Business Research Company
  • ID: 5939757
The microbiome market size has grown exponentially in recent years. It will grow from $0.57 billion in 2023 to $0.69 billion in 2024 at a compound annual growth rate (CAGR) of 20.2%. The growth observed in the historical period can be attributed to an increased demand for immunology, rising collaborations, government initiatives, increased healthcare expenditure, and growth in the number of healthcare facilities.

The microbiome market size is expected to see rapid growth in the next few years. It will grow to $1.24 billion in 2028 at a compound annual growth rate (CAGR) of 16.0%. The anticipated growth in the forecast period can be attributed to a rise in healthcare expenditure, an increasing demand for personalized medicine, growing funding, technological advances, and the rising prevalence of chronic diseases. Key trends in the forecast period include the use of artificial intelligence for enhanced analysis and process optimization, strategic collaborations and agreements to expand product portfolios, boost revenues, and establish category leadership. Additionally, there is an emphasis on investing in 3D printing technology for more accurate information and increased efficiency, increasing the number of pipeline studies to develop microbiome therapeutics for various diseases, exploring the development of oncology microbiome therapeutics to maximize revenues, and considering nanotechnology for identifying low-abundant samples to enhance the productivity, efficiency, and accuracy of precision technologies in use.

The growth of the microbiome market is being propelled by the increasing prevalence of inflammatory bowel disease (IBD). IBD comprises a group of chronic inflammatory disorders affecting the digestive tract, particularly the gastrointestinal (GI) tract. The heightened focus on the gut microbiome's role in IBD has spurred research, diagnostics, and therapies centered on the microbiome, fostering the market's expansion. For example, as of February 2021, Temple Health reported that over 1.6 million individuals in the United States are living with IBD, with expectations of a continued increase in prevalence. Consequently, the surge in IBD cases is anticipated to drive the growth of the microbiome market.

The rise in healthcare expenditure is poised to further propel the microbiome market's growth. Healthcare expenditure, encompassing the total amount spent on healthcare services and related activities within a specific healthcare system or economy, plays a crucial role in boosting the microbiome market. Increased investments in microbiome research and development, coupled with growing awareness of the microbiome's significance in human health, are driving the demand for microbiome-based therapies and products. As of May 2023, a report from the Office for National Statistics revealed that healthcare spending in the UK witnessed a 9.4% nominal and 9.7% real-term increase between 2020 and 2021. The total healthcare expenditure in the UK for 2021 amounted to $367.25 billion (£280.7 billion), with pharmaceutical expenditure at $51.84 billion (£39.6 billion) and spending on preventive care at $45.93 billion (£35.1 billion) in 2021, more than doubling from 2020. Thus, escalating healthcare expenditures are a key driver of the microbiome market's growth.

Technological improvement is emerging as a significant trend in the microbiome market. Major companies in the microbiome sector are actively developing advanced technological solutions, such as Seed's introduction of the Probiotic and Prebiotic Daily Synbiotic for both females and males. Seed's Daily Synbiotic adopts a microbe-system strategy, providing strain-specific benefits beyond digestive health, including cardiac safety, dermatological health, immune control, reproductive health, gut barrier integrity, and oxidative stress.

Strategic partnerships are a notable approach employed by major companies in the microbiome market for their growth and development strategies. These partnerships involve leveraging each other's strengths and resources to achieve mutual benefits. For instance, in June 2021, Illumina Inc., a US-based biotechnology company, formed a partnership with Microba Life Sciences Ltd., an Australia-based precision microbiome company. The collaboration aims to combine expertise in next-generation sequencing (NGS) and gut microbiome analysis to enhance data accuracy and comprehensiveness, make microbiome research more accessible in the Asia Pacific and Japan regions, and expedite the development of microbiome-based therapies and diagnostics.

In January 2021, Novozymes, a Denmark-based biotechnology company, acquired Microbiome Labs for an undisclosed amount. This acquisition is a strategic move to expand Novozymes' Human Health platform, providing access to a range of patented solutions and a network of health professionals. Microbiome Labs, a probiotics company, is based in the United States.

Major companies operating in the microbiome market report are Seres Therapeutics, Enterome Bioscience, Ferring Pharmaceuticals, Vedanta BioSciences, Second Genome Inc., Microbiotica, Rebiotix, Inc., Locus Biosciences, Osel Inc., Xbiome Co., Ltd., Microba Life Sciences, Biome Australia, Shoreline Biome, Leucine Rich Bio Pvt Ltd., BugSpeaks, KINS Co., Ltd., Yeda Research and Development Co. Ltd., China National Pharmaceutical Group Corporation, Atlas Biomed, BiomX Ltd., ImmuneBiotech Medical Sweden AB, MetaboGen AB, ADM Biopolis, Viome, PharmaBiome, NCCR Microbiomes, MaaT Pharma, Eligo Bioscience, T3 Pharmaceuticals, MicroBiome Therapeutics LLC, Second Genome, OpenBiome, Microbiome Insights Inc., lallemand Health Solutions, Mybiotics Pharma, DayTwo, Next Biosciences, ViThera Pharmaceuticals Inc., Inqaba Biotechnical Industries (Pty), SNIPR Biome, MyBiome.

North America was the largest region in the microbiome market in 2023. The regions covered in the microbiome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the microbiome market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The primary types of microbiomes include bacteria, archaea, viruses, and other microorganisms. Bacteria, single-celled microorganisms belonging to the domain Bacteria, are diverse and abundant life forms found in various environments. Products associated with microbiomes include therapeutics and diagnostics, and technologies such as genomics, proteomics, and metabolomics are employed in conditions such as inflammatory bowel disease, gastrointestinal disorders, metabolic disorders, cancers, and other diseases.

The microbiome market research report is one of a series of new reports that provides microbiome market statistics, including microbiome industry global market size, regional shares, competitors with a microbiome market share, detailed microbiome market segments, market trends, and opportunities, and any further data you may need to thrive in the microbiome industry. This microbiome market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The microbiome market consists of sales of firmicutes, bacteroidetes, and actinobacteria. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.

Table of Contents

1. Executive Summary2. Microbiome Market Characteristics3. Microbiome Market Trends and Strategies
4. Microbiome Market - Macro Economic Scenario
4.1. Impact of High Inflation on the Market
4.2. Ukraine-Russia War Impact on the Market
4.3. COVID-19 Impact on the Market
5. Global Microbiome Market Size and Growth
5.1. Global Microbiome Market Drivers and Restraints
5.1.1. Drivers of the Market
5.1.2. Restraints of the Market
5.2. Global Microbiome Historic Market Size and Growth, 2018-2023, Value ($ Billion)
5.3. Global Microbiome Forecast Market Size and Growth, 2023-2028, 2033F, Value ($ Billion)
6. Microbiome Market Segmentation
6.1. Global Microbiome Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Fecal Microbiota Transplantation (FMT)
  • Microbiome drugs
6.2. Global Microbiome Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Therapeutics
  • Diagnostics
6.3. Global Microbiome Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Genomics
  • Proteomics
  • Metabolomics
6.4. Global Microbiome Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Inflammatory Bowel Disease
  • Diabetes
  • Multiple Sclerosis
  • Rheumatoid Arthritis
  • Other Applications
7. Microbiome Market Regional and Country Analysis
7.1. Global Microbiome Market, Split by Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Microbiome Market, Split by Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Microbiome Market
8.1. Asia-Pacific Microbiome Market Overview
Region Information, Impact of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Microbiome Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Microbiome Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Microbiome Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Microbiome Market
9.1. China Microbiome Market Overview
9.2. China Microbiome Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Microbiome Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Microbiome Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Microbiome Market
10.1. India Microbiome Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Microbiome Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Microbiome Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Microbiome Market
11.1. Japan Microbiome Market Overview
11.2. Japan Microbiome Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Microbiome Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Microbiome Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Microbiome Market
12.1. Australia Microbiome Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Microbiome Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Microbiome Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Microbiome Market
13.1. Indonesia Microbiome Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Microbiome Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Microbiome Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Microbiome Market
14.1. South Korea Microbiome Market Overview
14.2. South Korea Microbiome Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Microbiome Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Microbiome Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Microbiome Market
15.1. Western Europe Microbiome Market Overview
15.2. Western Europe Microbiome Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Microbiome Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Microbiome Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Microbiome Market
16.1. UK Microbiome Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Microbiome Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Microbiome Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Microbiome Market
17.1. Germany Microbiome Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Microbiome Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Microbiome Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Microbiome Market
18.1. France Microbiome Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Microbiome Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Microbiome Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Microbiome Market
19.1. Italy Microbiome Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Microbiome Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Microbiome Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Microbiome Market
20.1. Spain Microbiome Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Microbiome Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Microbiome Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Microbiome Market
21.1. Eastern Europe Microbiome Market Overview
21.2. Eastern Europe Microbiome Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Microbiome Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Microbiome Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Microbiome Market
22.1. Russia Microbiome Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Microbiome Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Microbiome Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Microbiome Market
23.1. North America Microbiome Market Overview
23.2. North America Microbiome Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Microbiome Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Microbiome Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Microbiome Market
24.1. USA Microbiome Market Overview
24.2. USA Microbiome Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Microbiome Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Microbiome Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Microbiome Market
25.1. Canada Microbiome Market Overview
25.2. Canada Microbiome Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Microbiome Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Microbiome Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Microbiome Market
26.1. South America Microbiome Market Overview
26.2. South America Microbiome Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Microbiome Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Microbiome Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Microbiome Market
27.1. Brazil Microbiome Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Microbiome Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Microbiome Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Microbiome Market
28.1. Middle East Microbiome Market Overview
28.2. Middle East Microbiome Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Microbiome Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Microbiome Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Microbiome Market
29.1. Africa Microbiome Market Overview
29.2. Africa Microbiome Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Microbiome Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Microbiome Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Microbiome Market Competitive Landscape and Company Profiles
30.1. Microbiome Market Competitive Landscape
30.2. Microbiome Market Company Profiles
30.2.1. Seres Therapeutics
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Enterome Bioscience
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Ferring Pharmaceuticals
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Vedanta BioSciences
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Second Genome Inc.
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Microbiome Market Other Major and Innovative Companies
31.1. Microbiotica
31.2. Rebiotix, Inc
31.3. Locus Biosciences
31.4. Osel Inc.
31.5. Xbiome Co., Ltd
31.6. Microba Life Sciences
31.7. Biome Australia
31.8. Shoreline Biome
31.9. Leucine Rich Bio Pvt Ltd
31.10. BugSpeaks
31.11. KINS Co., Ltd
31.12. Yeda Research and Development Co. Ltd
31.13. China National Pharmaceutical Group Corporation
31.14. Atlas Biomed
31.15. BiomX Ltd
32. Global Microbiome Market Competitive Benchmarking33. Global Microbiome Market Competitive Dashboard34. Key Mergers and Acquisitions in the Microbiome Market
35. Microbiome Market Future Outlook and Potential Analysis
35.1 Microbiome Market in 2028 - Countries Offering Most New Opportunities
35.2 Microbiome Market in 2028 - Segments Offering Most New Opportunities
35.3 Microbiome Market in 2028 - Growth Strategies
35.3.1 Market Trend-based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic and Forecast Inflation Rates
36.4. Research Inquiries
36.5. About the Analyst
36.6. Copyright and Disclaimer

Executive Summary

Microbiome Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on microbiome market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia-Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis.
  • Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for microbiome? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? This report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
  • The impact of higher inflation in many countries and the resulting spike in interest rates.
  • The continued but declining impact of COVID-19 on supply chains and consumption patterns.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Report Scope

Markets Covered:
1) By Type: Bacteria; Archaea; Viruses; Other Microbiomes
2) By Product: Therapeutics; Diagnostics
4) By Technology: Genomics; Proteomics; Metabolomics
3) By End-Use: Infectious Diseases; Gastrointestinal Disorders; Metabolic Disorders; Cancers; Other Diseases

Sub segments: Infectious Diseases; Gastrointestinal Disorders; Metabolic Disorders; Cancers; Others; Genomics; Proteomics; Metabolomics

Key Companies Mentioned: Seres Therapeutics; Enterome Bioscience; Ferring Pharmaceuticals; Vedanta BioSciences; Second Genome Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes

Delivery Format: PDF, Word and Excel Data Dashboard

Companies Mentioned

  • Seres Therapeutics
  • Enterome Bioscience
  • Ferring Pharmaceuticals
  • Vedanta BioSciences
  • Second Genome Inc.
  • Microbiotica
  • Rebiotix, Inc
  • Locus Biosciences
  • Osel Inc.
  • Xbiome Co., Ltd
  • Microba Life Sciences
  • Biome Australia
  • Shoreline Biome
  • Leucine Rich Bio Pvt Ltd
  • BugSpeaks
  • KINS Co., Ltd
  • Yeda Research and Development Co. Ltd
  • China National Pharmaceutical Group Corporation
  • Atlas Biomed
  • BiomX Ltd
  • ImmuneBiotech Medical Sweden AB
  • MetaboGen AB
  • ADM Biopolis
  • Viome
  • PharmaBiome
  • NCCR Microbiomes
  • MaaT Pharma
  • Eligo Bioscience
  • T3 Pharmaceuticals
  • MicroBiome Therapeutics LLC
  • Second Genome
  • OpenBiome
  • Microbiome Insights Inc.
  • lallemand Health Solutions
  • Mybiotics Pharma
  • DayTwo
  • Next Biosciences
  • ViThera Pharmaceuticals Inc.
  • Inqaba Biotechnical Industries (Pty)
  • SNIPR Biome
  • MyBiome

Methodology

Loading
LOADING...